We initially selected a total of 1128 patients with primary gastric cancer who presented at Shandong Provincial Hospital between January 2018 and January 2022, and retrospectively collected their clinical and pathological data.
The inclusion and exclusion criteria for the present study are as follows. Namely, we enrolled (1) patients with primary gastric malignant tumors, (2) patients not receiving preoperative neoadjuvant chemotherapy, (3) patients in whom no distant metastases, such as liver or lung metastases, were found on preoperative ultrasound and computed tomography (CT) examinations, (4) patients who underwent radical resection of gastric cancer, (5) patients with a postoperative pathology of adenocarcinoma or signet ring cell carcinoma according to the WTO pathological classification, (6) patients who did not take anticoagulant drugs (such as aspirin) prior to surgery, and (7) patients who denied any previous coagulation disorder.
Among the identified patients, we selected 516 patients with T4a gastric cancer in order to exclude the influence of tumor T stage, and retrospectively analyzed preoperative baseline characteristics, preoperative laboratory tests, and postoperative pathological results for these patients (Figure 1).
This work is reported in accordance with Strengthening the Reporting of Cohort Studies in Surgery (STROCSS) guidelines.
Free full text: Click here